Patents by Inventor Boris Ivandic

Boris Ivandic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for prediction of prognosis of sepsis
    Patent number: 11041864
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 22, 2021
    Assignees: LSI MEDIENCE CORPORATION, MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo
  • METHOD FOR PREDICTION OF PROGNOSIS OF SEPSIS
    Publication number: 20130288276
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Application
    Filed: January 10, 2012
    Publication date: October 31, 2013
    Applicants: MOCHIDA PHARMACEUTICAL CO., LTD., Mitsubishi Chemical Medience Corporation
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo
  • D-DIMER, TROPONIN, AND NT-PROBNP FOR PULMONARY EMBOLISM
    Publication number: 20130236916
    Abstract: The present invention relates to a method of diagnosing acute pulmonary embolism (PE) in a subject including a) determining the amount of fibrin-fibrinogen degradation products, in particular D-dimer in a sample of the subject; b) determining the amount of a natriuretic peptide in a sample of the subject; c) determining the amount of a cardiac troponin in a sample of the subject; and d) comparing the amounts determined in steps a) to c) to reference amounts, thereby establishing the diagnosis. Included is also a method of deciding on a therapy of a subject diagnosed with PE and a method of monitoring the therapy.
    Type: Application
    Filed: April 24, 2013
    Publication date: September 12, 2013
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Eberhard Spanuth, Boris Ivandic
  • D-dimer, troponin, and NT-proBNP for pulmonary embolism
    Patent number: 8444932
    Abstract: The present invention relates to a method of diagnosing acute pulmonary embolism (PE) in a subject including a) determining the amount of fibrin-fibrinogen degradation products, in particular D-dimer in a sample of the subject; b) determining the amount of a natriuretic peptide in a sample of the subject; c) determining the amount of a cardiac troponin in a sample of the subject; and d) comparing the amounts determined in steps a) to c) to reference amounts, thereby establishing the diagnosis. Included is also a method of deciding on a therapy of a subject diagnosed with PE and a method of monitoring the therapy.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: May 21, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Eberhard Spanuth, Boris Ivandic
  • D-DIMER, TROPONIN, AND NT-PROBNP FOR PULMONARY EMBOLISM
    Publication number: 20110129936
    Abstract: The present invention relates to a method of diagnosing acute pulmonary embolism (PE) in a subject including a) determining the amount of fibrin-fibrinogen degradation products, in particular D-dimer in a sample of the subject; b) determining the amount of a natriuretic peptide in a sample of the subject; c) determining the amount of a cardiac troponin in a sample of the subject; and d) comparing the amounts determined in steps a) to c) to reference amounts, thereby establishing the diagnosis. Included is also a method of deciding on a therapy of a subject diagnosed with PE and a method of monitoring the therapy.
    Type: Application
    Filed: February 3, 2011
    Publication date: June 2, 2011
    Inventors: Eberhard Spanuth, Boris Ivandic